GLP-1 prices drop?

I saw a post on another forum that said because a patent has expired, the price of a certain drug should go down in Canada, but somebody refilled their script and it was the same cost. Anyone know anything about this? I'm pretty sure that poster said this happened in January of this year. Is that guy full of it?
 
I'm wondering the same thing @Nat. I read somewhere the price reduction in Canada isn't immediate. The patent may have expired in January, but generics still have to be manufactured & approved. It could take several more months for them to actually be available.
 
Docs are saying that cheaper options should be available eventually as there are several generic brands awaiting approval, and once approved these generics could be approximately 65% cheaper than what is currently available. The name brand may also drop to compete. But generics will be the cheapest. Expect these to start hitting the market in the fall, allegedly.
 
The WSJ numbers are US pharmacy pricing - compounded hasn't followed the same curve because the cost base is different. Brand cuts pressure the insurance side; compounded stays tied to API and overhead.
 
It's crazy how fast Indian manufacturers move once patents expire. Check India's CDSCO database or WHO prequalified list if you're looking at pricing or availability, good way to spot legitimate generics.
 
The Indian generic speed after patent drop is the actual price mechanism - the politician-announced deals are getting credit for what the market was already set up to do. CDSCO and WHO prequalified list are the right tools for confirming which generics are legitimate.
 
You must log in or register to reply here.
Back
Top